Biogen | BIIB - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2025 3.83 4.81 Oct/28
FY2026Q2 Jun/2026 3.60 3.21 5.47 Jul/29
FY2026Q1 Mar/2026 3.57 3.06 3.02 Apr/29
FY2025Q4 Dec/2025 1.99 1.74 3.44 Feb/06
FY2025Q3 Sep/2025 4.81 3.84 4.08 Oct/30




Eps Cambiamento Data
AbbVie USD 3.65 1 2026-06
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
ALKERMES USD 0 0.4 2026-06
Amgen USD 6.29 1.14 2026-06
Bayer EUR 0.95 1.76 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
Incyte USD 3.09 1.28 2026-06
Merck USD -0.13 1.15 2026-06
Moderna USD -1.97 1.43 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06
Pfizer USD 0.77 0.02 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.09 0.21 2026-06
Sanofi EUR 2.17 2.84 2026-03
Sarepta Therapeutics USD 0.64 2.52 2026-06
Teva Pharmaceutical Industries USD 0.06 1.51 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
United Therapeutics USD 7.27 1.45 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06